PRMT5 and glioblastoma: In addition, PRMT5 silencing or inhibition (EPZ015666) induced antitumor effect in glioblastoma cells in vitro and in an in vivo PDX model by removing detained introns, thereby regulating rapid expression of transcripts associated with proliferation (145).